Literature DB >> 21098705

p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.

Christopher L Hall1, Honglai Zhang, Shobun Baile, Mats Ljungman, Stuart Kuhstoss, Evan T Keller.   

Abstract

Osteoblastic bone metastases are the most common metastases produced by human prostate cancers (PCa). Deregulated activity of Wnt growth factors resulting from overexpression of the Wnt inhibitor Dickkopf-1 (DKK-1) is known to contribute to formation of the osteoblastic component of PCa skeletal bone metastases. In this study, we report that DKK-1 knockdown in osteolytic human PCa cells unexpectedly delays the development of both soft tissue and osseous lesions. PCa cells deficient in DKK-1 expression did not increase canonical Wnt signaling in target osteoblast cell lines; however, DKK-1 knockdown PCa cells exhibited increased expression of the CDK inhibitor p21(CIP1/WAF1) and a 32% increase in G(1) arrest compared with control cells. Ablating p21(CIP1/WAF1) in PCa cells deficient in DKK-1 was sufficient to rescue tumor growth. Collectively, our findings demonstrate that DKK-1 overexpression supports tumor growth in part by restricting expression of p21(CIP1/WAF1) through a mechanism independent of canonical Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098705      PMCID: PMC3059079          DOI: 10.1158/0008-5472.CAN-10-0440

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

2.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

3.  Prostate cancer cells promote osteoblastic bone metastases through Wnts.

Authors:  Christopher L Hall; Anna Bafico; Jinlu Dai; Stuart A Aaronson; Evan T Keller
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

Review 4.  Wnt signalling and prostate cancer.

Authors:  G W Yardy; S F Brewster
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

5.  Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Authors:  Matthew R Smith; Fairooz Kabbinavar; Fred Saad; Arif Hussain; Marc C Gittelman; David L Bilhartz; Chris Wynne; Robin Murray; Norman R Zinner; Claude Schulman; Ronald Linnartz; Ming Zheng; Carsten Goessl; Yong-Jiang Hei; Eric J Small; Richard Cook; Celestia S Higano
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

6.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction.

Authors:  A Glinka; W Wu; H Delius; A P Monaghan; C Blumenstock; C Niehrs
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

Review 7.  Osteoblasts in prostate cancer metastasis to bone.

Authors:  Christopher J Logothetis; Sue-Hwa Lin
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

8.  Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.

Authors:  Yan-Xi Sun; Abraham Schneider; Younghun Jung; Jianhua Wang; Jinlu Dai; Jingcheng Wang; Kevin Cook; Nadir I Osman; Amy J Koh-Paige; Hyusuk Shim; Kenneth J Pienta; Evan T Keller; Laurie K McCauley; Russell S Taichman
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

9.  Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas.

Authors:  Tark A Bismar; Peter A Humphrey; David J Grignon; Hanlin L Wang
Journal:  Am J Clin Pathol       Date:  2004-04       Impact factor: 2.493

10.  Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

Authors:  Lisa G Horvath; Susan M Henshall; C-Soon Lee; James G Kench; David Golovsky; Phillip C Brenner; Gordon F O'Neill; Raji Kooner; Phillip D Stricker; John J Grygiel; Robert L Sutherland
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

View more
  27 in total

1.  Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract.

Authors:  Vatsal Mehta; Lisa L Abler; Kimberly P Keil; Christopher T Schmitz; Pinak S Joshi; Chad M Vezina
Journal:  Dev Dyn       Date:  2011-09-20       Impact factor: 3.780

2.  Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.

Authors:  Mario R Calderon; Mark Verway; Beum-Soo An; Analisa DiFeo; Tarek A Bismar; David K Ann; John A Martignetti; Tali Shalom-Barak; John H White
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

3.  Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth.

Authors:  Gulzar Ahmad; Rana El Sadda; Galina Botchkina; Iwao Ojima; James Egan; Mansoor Amiji
Journal:  Cancer Lett       Date:  2017-08-11       Impact factor: 8.679

4.  Wnt signaling in castration-resistant prostate cancer: implications for therapy.

Authors:  Noriko N Yokoyama; Shujuan Shao; Bang H Hoang; Dan Mercola; Xiaolin Zi
Journal:  Am J Clin Exp Urol       Date:  2014-04-15

5.  RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Authors:  Guoyu Yu; Yu-Chen Lee; Chien-Jui Cheng; Chuan-Fen Wu; Jian H Song; Gary E Gallick; Li-Yuan Yu-Lee; Jian Kuang; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

6.  Wnt and Wnt inhibitors in bone metastasis.

Authors:  Joseph L Sottnik; Christopher L Hall; Jian Zhang; Evan T Keller
Journal:  Bonekey Rep       Date:  2012-07-04

7.  DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.

Authors:  Mitchell E Menezes; Aparna Mitra; Lalita A Shevde; Rajeev S Samant
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

Review 8.  Wnt/β-catenin signalling in prostate cancer.

Authors:  Robert M Kypta; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

Review 9.  Wnt and SHH in prostate cancer: trouble mongers occupy the TRAIL towards apoptosis.

Authors:  A A Farooqi; S Mukhtar; A M Riaz; S Waseem; S Minhaj; B A Dilawar; B A Malik; A Nawaz; S Bhatti
Journal:  Cell Prolif       Date:  2011-10-04       Impact factor: 6.831

10.  Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway.

Authors:  Min Xu; Shusheng Wang; Y U Song; Jianhua Yao; Kun Huang; Xiaojue Zhu
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.